Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Shuangqiao Yanjing Pharmaceutical is a prominent Chinese pharmaceutical enterprise specializing in the integration of traditional Chinese medicine (TCM) and modern chemical pharmaceuticals. Based in the Shuangqiao area of Beijing, the company is a key manufacturer of essential drugs, including Methimazole for hyperthyroidism and various cardiovascular and oncology medications. It is also highly regarded as a major supplier of standardized TCM decoction pieces and herbal extracts used extensively in clinical treatments and research. Affiliated with the state-owned Beijing Capital Agribusiness & Food Group, the company operates high-standard GMP manufacturing facilities and plays a vital role in ensuring the national supply of critical active pharmaceutical ingredients and finished dosages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Shuangqiao Yanjing Pharmaceutical.